Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Eric Dube, Ph.D., president and chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, ...

Received 693 new patient start forms for FILSPARI® (sparsentan) in the fourth quarter of 2024; approximately $50 million in preliminary net product sales of FILSPARI for the fourth quarter ...

Learn more about whether Travere Therapeutics, Inc. or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Travere Therapeutics (TVTX) just hit a fresh 52 week high after the FDA removed an advisory committee review and relaxed REMS monitoring for FILSPARI, sharpening focus on January’s FSGS approval ...

One analyst believes the company's Filspari has blockbuster potential if it earns FDA approval for a new indication. A decision on that should come very shortly. The stock of commercial-stage biotech ...

SAN DIEGO, December 11, 2025--(BUSINESS WIRE)--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on December 10, 2025, the Compensation Committee of its Board of Directors granted ...

Travere Therapeutics Inc’s stock reached a notable milestone, hitting a 52-week high of 37.76 USD. This marks a significant achievement for the company, reflecting a robust growth trajectory over the ...

Investing.com - Travere Therapeutics (NASDAQ:TVTX) stock gained on Tuesday following positive commentary from Cantor Fitzgerald regarding the company’s upcoming regulatory decision for its kidney ...

Detailed price information for Travere Therapeutics Inc (TVTX-Q) from The Globe and Mail including charting and trades.

Travere Therapeutics › The stock of commercial-stage biotech Travere Therapeutics (NASDAQ: TVTX) barreled into the late holiday period in style. On a pair of new analyst notes covering the company, ...

ASN Kidney Week, held in November, featured leading-edge science in kidney care, with evidence supporting new drugs to treat immunoglobulin A nephropathy, address chronic kidney disease in specific ...